$591.28▼-2.03 (-0.34%)
After Hours:$590.00-1.28 (-0.22%)
United Therapeutics Corporation (UTHR)
R&D Expenses
$703.20M
TTM · Period ending: · USD

UTHR R&D Expenses
Latest reported$703.20Mperiod ending
Latest reported$703.20Mperiod ending
UTHR R&D Expenses ($11.00M → $703.20M)
Annual R&D Expenses
High-resolution chart · PNG
What is r&d expenses?
Research and development spending.
UTHR r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 550,000,000 | |
| 481,000,000 | |
| 408,000,000 | |
| 322,900,000 | |
| 540,100,000 | |
| 357,700,000 | |
| 1,182,600,000 | |
| 357,900,000 | |
| 264,600,000 | |
| 147,600,000 | |
| 245,098,000 | |
| 242,549,000 | |
| 299,348,000 | |
| 173,387,000 | |
| 180,015,000 | |
| 166,761,000 | |
| 122,188,000 | |
| 239,181,000 | |
| 83,352,000 | |
| 57,570,000 | |
| 36,052,000 | |
| 30,602,000 | |
| 35,417,000 | |
| 26,778,000 | |
| 32,590,191 | |
| 70,187,748 | |
| 30,700,000 | |
| 11,000,000 |
Explore More
UTHR Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance